Does CBC help with pain?

Cannabichromene (CBC) relieves pain without intoxication. It blocks pain signals while reducing inflammatory responses that worsen discomfort. CBC's effects last longer than many prescription pain medications and don’t lead to tolerance. Many people use CBC to treat nerve pain, joint inflammation, and muscle soreness.

CBC works independently and synergistically with other cannabinoids to amplify pain relief through the entourage effect. With a precise blend of CBC, CBD, THC, CBG, and CBN, our Pain Plus gummies leverage this natural synergy with a multi-cannabinoid formula that outperforms single-compound solutions for stubborn pain.

How does CBC make you feel?

CBC is the third most abundant cannabinoid in cannabis, much less known than cannabidiol (CBD) or tetrahydrocannabinol (THC). Similarly to CBD, CBC interacts with your endocannabinoid system (ECS) without binding strongly to CB1 receptors in your brain. This is why CBC is a non-psychoactive cannabinoid. It doesn't trigger the intoxicating effects associated with THC while still delivering therapeutic benefits through alternative receptors.

CBC affects pain perception through sophisticated mechanisms of action involving TRPV1 and anandamide signaling pathways. As a cannabinoid TRPA1 agonist, CBC activates TRPV1 receptors (the same ones triggered by capsaicin in hot peppers), which leads to desensitization of pain signals after initial activation. CBC also inhibits the enzymes that break down anandamide, your body's natural pain-fighting endocannabinoid, allowing it to remain active longer for extended analgesic effects.

People who use CBC typically feel:

• Pain melting away within the first hour.
• Less stiffness and swelling in troubled joints and muscles.
• A gentle mood lift without the mental fog of THC.
• Physically relaxed but still alert and functional.
• Better concentration once pain stops stealing your attention.
• Easier, more fluid movement throughout the day.
• Relief that feels in tune with your body.

Unlike prescription painkillers that often cause mental cloudiness, CBC maintains cognitive clarity while blocking pain signals. According to clinical research in murine models, CBC has therapeutic potential against neuropathic pain. It also shows versatility by reducing acute and chronic inflammatory pain while decreasing sensitivity to thermal pain in tail-flick assays. In other words, CBC reduces acute and chronic inflammatory pain and decreases sensitivity to harmful heat stimuli.

Is a CBC good for inflammation?

Inflammation is often the root cause of most chronic pain conditions. CBC fights this underlying trigger, whether it’s acute bouts of inflammation or chronic inflammatory conditions. Here’s how CBC reduces inflammation in the body:

• CBC inhibits inflammatory enzymes that produce pain-causing compounds. Sepulveda, et. al. explain that CBC blocks nitrite production and suppresses expression of inflammatory mediators such as pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, and INF-γ). These molecules signal pain responses, breaking the communication network that drives inflammation.
• According to Sepulveda and his team, CBC binds to specialized receptors, like TRPA1 (at concentrations of 90 nM) and TRPV channels, which stimulate and desensitize pain pathways, creating lasting relief through receptor modulation.
• CBC also blocks the enzyme monoacylglycerol lipase while maintaining anandamide levels and establishing an endocannabinoid profile that counteracts pain and inflammation.
• CBC limits immune cell infiltration at inflammation sites while triggering anti-inflammatory cascades through MAPK signaling pathways.
• CBC shields nerve cells from inflammatory damage by neutralizing oxidative stress and neuroinflammation. This prevents the sensitization that transforms acute pain into chronic conditions.

CBC's pain-relieving effects surpass many synthetic anti-inflammatory drugs without the harsh side effects on your digestive system or kidneys. But CBC performs best as part of a team. 

Our Pain Plus gummies harness natural cannabis synergy with a precise formula of five cannabinoids: 10 mg CBC, 10 mg CBD, 10 mg THC, 5 mg cannabigerol (CBG), and 5 mg cannabinol (CBN) in each delicious tangerine-flavored gummy. They target every aspect of pain, from inflammation to nerve signaling, for complete relief you can feel.

CBC dosage for pain relief

Microdosing is the best way to maximize CBC's potential health benefits while treating pain and other medical conditions. Small, precise doses deliver therapeutic effects while minimizing adverse effects. CBC's effectiveness amplifies through the entourage effect when combined with other cannabinoids from the cannabis plant, enhancing its natural anti-inflammatory properties.

When fighting persistent pain, stick to a regular dosing schedule to keep cannabinoid levels steady in your body. This prevents pain from breaking through between doses and stops your system from building tolerance. By working with your body's natural chemistry, CBC tackles different pain types through multiple pathways, giving you lasting relief without needing constantly increasing amounts.

When to take CBC

You can take CBC whenever you feel pain, but scheduling consumption around certain activities can provide more benefits.

• Take CBC in the morning to handle daytime discomfort without feeling drowsy.
• Use evening doses to prevent pain from interrupting your sleep.
• Take CBC before exercise or physical activity to stop pain before it starts.
• Stick to a regular schedule to maintain effective cannabinoid levels in your system.

CBC works best when taken at the first hint of pain, so don't wait until discomfort becomes unbearable. Our Pain Plus edibles make effective pain management simple and delicious. Our precise formula takes the guesswork out of dosing, and you get to enjoy a tangy tangerine flavor while you relieve the pain. 

These Delta 9 gummies take 30–120 minutes to take effect, and the beneficial properties can last up to eight hours.

What are the side effects of CBC?

CBC has an excellent safety profile, but extremely high doses may produce unwanted effects such as:

• Dry mouth.
• Temporary drowsiness.
• Mild digestive discomfort.
• Changes in appetite.
• Interaction with certain medications.
• Lightheadedness in sensitive individuals.

Most CBC users experience no side effects when following appropriate microdosing protocols. CBC doesn't cause liver damage, kidney problems, or addiction even with regular use. 

What are the best gummies for pain relief?

namaCBD makes the best adult gummies. Our pain-relief gummies offer science-backed, naturally derived relief with predictable, consistent dosing. 

Pain Plus gummies deliver comprehensive relief through a five-cannabinoid formula that targets multiple pain pathways, tackling inflammation while blocking pain signals. These tangerine-flavored gummies leverage the entourage effect, where cannabinoids work together to amplify each other's benefits.

If you’re feeling tense, Relax Plus gummies melt away muscle knots and stress-induced pain with their powerful 5 mg THC and 25 mg CBD combination. The juicy watermelon flavor makes these tension-dissolving gummies a treat that works.

Looking for everyday comfort? Bliss gummies hit the sweet spot with their 5 mg THC to 5 mg CBD ratio. These melon-flavored marvels tackle mild to moderate discomfort while lifting your mood.

All nama products undergo rigorous third-party testing to verify potency and purity. Made with premium hemp-derived cannabinoids from American farms, these vegan, gluten-free gummies contain no artificial additives. 

Order from nama today and never worry about unpredictable pain relief again.

Resources

Raup-Konsavage WM, Sepulveda DE, Wang J, Dokholyan NV, Vrana KE, Graziane NM. Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests. Biomedicines. 2023 Dec 29;12(1):83. doi: 10.3390/biomedicines12010083. PMID: 38255191; PMCID: PMC10813533.

Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The Potential of Cannabichromene (CBC) as a Therapeutic Agent. J Pharmacol Exp Ther. 2024 Oct 18;391(2):206-213. doi: 10.1124/jpet.124.002166. PMID: 38777605; PMCID: PMC11493452.

Further reading

Is indica or sativa better suited for pain relief?

Best type of CBD for joint pain relief

Taking small amounts of cannabis for pain

How does CBN tackle chronic pain?

Why is hybrid cannabis much more suited for pain relief?

Can you feel the entourage effect?

Best anti-inflammatory cannabis terpenes

nama CBD FDA & legal disclaimer

Our products are not intended to diagnose, treat, cure, or prevent any disease. They are not a replacement for prescription medications and have not been evaluated by the Food and Drug Administration (FDA).

The information provided on this website does not and is not intended to constitute legal advice or any statements of the status of any laws. Any information, content, and materials available on this site are for general informational purposes only and are not intended to be relied upon for any purpose.

Readers of this website should contact their attorney to obtain advice concerning any particular legal matter, including decisions on what products are, or are not, legal to sell, possess, or consume. No reader, user, or browser of this site should act or refrain from acting based on information on this site without first seeking legal advice from their own counsel in the relevant jurisdiction.

Only your attorney can provide assurances that the information contained herein—and your interpretation of it—is applicable or accurate for your particular situation. Use of, and access to, this website or any of the links or resources contained within the site do not create an attorney-client relationship between the reader, user, or browser, and website authors, contributors, contributing law firms, or committee members and their respective employers.